Care Of Diabetic Patients Research Articles

Medications for Managing Preexisting and Gestational Diabetes in Pregnancy

Persons with gestational and pregestational diabetes during pregnancy may require pharmacologic agents to achieve pregnancy glycemic targets, and the available medications for use in pregnancy are limited. Insulin is the only FDA-approved medication for use in pregnancy and has the greatest evidence for safety and efficacy. Metformin and glyburide are the most commonly used oral agents in pregnancy. Understanding each medication's unique pharmacokinetics, potential side effects, fetal or childhood risks, gestational age of medication initiation and patient's diabetes care barriers are important aspects of shared decision-making and choosing a regimen that will achieve glycemic and pregnancy goals.

"Everything in One Place": Stakeholder Perceptions of Integrated Medical and Social Care for Diabetes Patients in Western Maryland.

Patients with type 2 diabetes frequently have both medical- and health-related social needs that must be addressed for optimal disease management. Growing evidence suggests that intersectoral partnerships between health systems and community-based organizations may effectively support improved health outcomes for patients with diabetes. The purpose of this study was to describe stakeholders' perceptions of the implementation factors associated with a diabetes management program, an intervention involving coordinated clinical and social services supports to address both medical- and health-related social needs. This intervention delivers proactive care alongside community partnerships, and leverages innovative financing mechanisms. Qualitative study with semi-structured interviews. Study participants included adults (18 years or older) who were patients with diabetes and essential staff (e.g., members of a diabetes care team, health care administrators) and leaders of community-based organizations. We used the Consolidated Framework for Implementation Research (CFIR) to develop a semi-structured interview guide designed to elicit perspectives from patients and essential staff on their experiences within an outpatient center to support patients with chronic conditions (the CCR) as a part of an intervention to improve care for patients with diabetes. Interviews illuminated three key takeaways: (1) team-based care held an important role in promoting accountability across stakeholders motivating patient engagement and positive perceptions, (2) mission-driven alignment across the health care and community sectors was needed to synergize a broad range of efforts, and (3) global payment models allowing for flexible resource allocation can invaluably support the appropriate care being directed where it is needed the most whether medical or social services. The views and experiences of patient and essential staff stakeholder groups reported here thematically according to CFIR domains may inform the development of other chronic disease interventions that address medical- and health-related social needs in additional settings.

Continuum of Care for Diabetic Patients during COVID-19 Pandemic in Primary Health Care, Egypt

Continuum of Care for Diabetic Patients during COVID-19 Pandemic in Primary Health Care, Egypt

Assessment of quality of care of diabetic patients by health-care professionals in a city – A community-based cross-sectional study

Background: Diabetes is undoubtedly one of the most challenging health problems of the 21st century. Patients from poor parts of the Indian urban population do not frequently have access to these health benefits despite having access to reliable screening methods and antidiabetic drugs. Hence, this study was designed to assess the quality of care of diabetic patients by health-care professionals in a city. Aims and Objectives: This study aims to assess the quality of care of diabetic patients by health-care professionals in a city. Materials and Methods: A community-based cross-sectional study was conducted in the city of Aurangabad, Maharashtra. The sample size calculated was 145 and we used the probability proportionate to size sampling technique to identify the number of participants. Results: Overall 9% of patients had good quality of care. Almost 61.4% were dissatisfied with their treating physician. Almost all patients going to public health centers complained of the unavailability of medications whereas three-fourth (73.5%) of patients complained of unavailability of investigations. Only 23.4% of diabetic patients were referred to a specialist for screening or management of complications. Conclusion: Quality of care assessed through patient’s opinion showed that most diabetic patients were not well informed about comprehensive diabetic management by the health-care providers. Glycemic controls in diabetic patients were far below recommended standards.

Natural Compounds and Biopolymers-Based Hydrogels Join Forces to Promote Wound Healing.

Rapid and complete wound healing is a clinical emergency, mainly in pathological conditions such as Type 2 Diabetes mellitus. Many therapeutic tools are not resolutive, and the research for a more efficient remedial remains a challenge. Wound dressings play an essential role in diabetic wound healing. In particular, biocompatible hydrogels represent the most attractive wound dressings due to their ability to retain moisture as well as ability to act as a barrier against bacteria. In the last years, different functionalized hydrogels have been proposed as wound dressing materials, showing encouraging outcomes with great benefits in the healing of the diabetic wounds. Specifically, because of their excellent biocompatibility and biodegradability, natural bioactive compounds, as well as biomacromolecules such as polysaccharides and protein, are usually employed in the biomedical field. In this review, readers can find the main discoveries regarding the employment of naturally occurring compounds and biopolymers as wound healing promoters with antibacterial activity. The emerging approaches and engineered devices for effective wound care in diabetic patients are reported and deeply investigated.

Barriers and solutions for the integrated care of diabetic patients from the point of view of general practitioners in Latvia.

Ambulatory care sensitive indicators for chronic care patients, such as avoidable hospitalizations and preventable mortality, show worse results in Latvia in comparison with the EU average. Previous studies reveal the situation is not far behind in terms of the quantity of diagnostics and consultations, but it is possible to prevent at least 14% of hospitalizations in the chronic patient group. The aim of this study is to find out the opinions of GPs on the barriers and solutions for better care results for diabetic patients in the context of applying an integrated care approach. A qualitative study was conducted in the form of semi-strucured in-depth interviews (5 themes, 18 questions), and analyzed using an inductive thematic analysis. The online interviews were conducted in May and April 2021. The respondents were GPs representing different rural regions (n=26). The results of the study reveal that the main barriers to integrated care are: the workload of GPs, especially in COVID conditions; the limited visit time; the lack of focused informational handouts; long queues for secondary care; and the lack of electronic patient health records (EHRs). GPs point to the need to set up patient EHRs, to develop diabetes training rooms in regional hospitals, and to expand GP practice with a third nurse. Special attention should be paid to developing integrated care tools at the healthcare system level and patient data digitization and care of socially isolated and sedentary patients by developing home care services, communication tools and integrating primary, secondary and social care at the regional level.

Type 1 Diabetes Mellitus: A Review on Advances and Challenges in Creating Insulin Producing Devices.

Type 1 diabetes mellitus (T1DM) is the most common autoimmune chronic disease in young patients. It is caused by the destruction of pancreatic endocrine β-cells that produce insulin in specific areas of the pancreas, known as islets of Langerhans. As a result, the body becomes insulin deficient and hyperglycemic. Complications associated with diabetes are life-threatening and the current standard of care for T1DM consists still of insulin injections. Lifesaving, exogenous insulin replacement is a chronic and costly burden of care for diabetic patients. Alternative therapeutic options have been the focus in these fields. Advances in molecular biology technologies and in microfabrication have enabled promising new therapeutic options. For example, islet transplantation has emerged as an effective treatment to restore the normal regulation of blood glucose in patients with T1DM. However, this technique has been hampered by obstacles, such as limited islet availability, extensive islet apoptosis, and poor islet vascular engraftment. Many of these unsolved issues need to be addressed before a potential cure for T1DM can be a possibility. New technologies like organ-on-a-chip platforms (OoC), multiplexed assessment tools and emergent stem cell approaches promise to enhance therapeutic outcomes. This review will introduce the disorder of type 1 diabetes mellitus, an overview of advances and challenges in the areas of microfluidic devices, monitoring tools, and prominent use of stem cells, and how they can be linked together to create a viable model for the T1DM treatment. Microfluidic devices like OoC platforms can establish a crucial platform for pathophysiological and pharmacological studies as they recreate the pancreatic environment. Stem cell use opens the possibility to hypothetically generate a limitless number of functional pancreatic cells. Additionally, the integration of stem cells into OoC models may allow personalized or patient-specific therapies.

Polish Patients' Needs and Opinions about the Implementation of Pharmaceutical Care in Diabetes.

The study aimed to get to know patients' opinions on implementing pharmaceutical care for diabetic patients in a community pharmacy to prevent and effectively and holistically approach the treatment of people with diabetes. It was based on an authorial survey form and conducted from August to October 2021 in a community pharmacy in Poznan, Poland. A total of 131 pharmacy patients over 18 years were included in the study. Results showed that the vast majority of patients confirmed their interest in pharmaceutical care in diabetes conducted by pharmacists. Moreover, 79.4% of respondents would like to benefit from medicines use review, while 87.0% confirmed an interest in the 'New Drug' service, with diabetic patients being particularly interested in this (p = 0.2447). Most respondents were also interested in education on how to use a glucose meter, administer insulin and use a lancing device. In addition, the study showed patients' insufficient knowledge about risk factors and prevention of diabetes with the need for patient education. As the source of funding, 91.7% of diabetic patients indicated the National Health Fund. Given that such a service has not been implemented in Poland yet, this study may support established teams at the Supreme Pharmaceutical Chamber or the Ministry of Health in introducing such new services.

The impact of continuous versus traditional glucose monitoring on prenatal care for pregnant diabetic patients

The impact of continuous versus traditional glucose monitoring on prenatal care for pregnant diabetic patients

Pancreas Transplantation Alone for Brittle Diabetes Mellitus

Only about 8% of all pancreas transplants for insulin-dependent diabetes mellitus are performed in the Pancreas Transplant Alone (PTA) category. PTAs are primarily performed in diabetic, non-uremic patients with unstable glucose control, hypoglycemia unawareness, and an increased risk of diabetes-related mortality, and who have failed all of the more traditional approaches to glycemic control. Tremendous, yet not widely noticed, progress in PTA outcome has been made over the past two decades. PTA is a very safe procedure with 1-and 5-year patient survival rates of 98.3% and 90.5% according to International Pancreas Transplant Registry (IPTR) data. Since the introduction of tacrolimus and mycophenolate mofetil maintenance therapy in the 1990s and the use of depleting antibody induction therapy, PTA graft survival rates at 1-and 5-years posttransplant are 87.2% and 65.0%. To avoid the need for a future kidney after pancreas (KAP) transplant due to impaired pretransplant native kidney function and the posttransplant use of calcineurin inhibitors, the estimated Glomerular Filtration Rate (eGFR) of PTA candidates should be well within the normal range and preferably > 80 mL/min/1.73m². PTAs with stable, long-term function have been shown to have a positive impact on secondary complications of diabetes mellitus. Considering the significantly improved outcome results, PTA should become the pancreas transplant option of choice before the manifestation of devastating secondary complications (kidney failure, cardio-cerebrovascular events, and blindness) that require simultaneous pancreas and kidney (SPK) transplants in qualified candidates, but with higher morbidity and mortality risks. It is important for diabetologists, endocrinologists, and other health professionals involved in the care of diabetic patients to learn about these positive PTA outcome results. Despite improvements in intensive insulin therapy, insulin-delivering devices, bioartificial pancreas, and islet transplantation, a successful PTA is the only treatment option for patients with brittle diabetes that consistently restores normal glucose homeostasis long-term without exposing recipients to the risks of severe hypoglycemia and prevents, halts, or reverses the development or progression of secondary diabetes complications.

Systemic therapy of inflammatory breast cancer with type 2 diabetes mellitus – Prevention of high risk of radiation-induced progression of tumor tissue cancer

Introduction. Cancer mortality in diabetic patients has been reported to increase moderately compared to non-diabetic patients. The aim of the study aimed to assess the findings and identify radiotherapy's role in the comprehensive care of diabetic IBC patients with various hyperglycemia correction strategies. Methods. Patients with diabetes have shown a higher risk of radiation-induced cancer progression for tumor tissue, especially for inflammatory form. For 7 patients, to continue systematic chemotherapy with a scheme change (consecutive anthracyclines-taxanes, 2-week interval) and insulin with individual scheme for hyperglycemia correction on the basis of glycemic control – 1st group, the other (7 patients) – 2nd group, was given radiotherapy to the breast gland and lymphatic drainage ways. 45–50 Grey was prescribed for 25-28 fractions (per 1.8-2.0 Grey), 46–50 Grey in 23-25 fractions were used for zones of regional metastasis and for hyperglycemia correction metformin 2000 mg/day PO divided q8-12hr with meal on the basis of glycemic control. Results. Assessed were the number of patients who qualified for surgery and overall survival for 24 months. 2nd group showed a superior response following resistance to prior systemic treatment. Thus, 5 (71.41%) of the 7 patients exhibited a consistent response – complete or partial regression. There were only 2 individuals (28.61%) who responded to treatment among the patients who maintained chemotherapy. Conclusions. Breast cancer of the aggressive IBC variety requires multidisciplinary treatment from breast surgery, medical, and radiation oncology. Patients with diabetes appear to experience more side effects from radiation therapy than patients without the disease. Hyperglycemia, higher total RT doses, and radiosensitizers are a few techniques that can improve the impact of RT on local-regional management. Local-regional control rates for IBC are increasing with an individual patient strategy. Metformin also improves insulin resistance and has anticancer benefits.

Epidemiological and Hemato-biochemical urinary profile of diabetic patients received in consultation at anastasis health center in Nongo (Conakry), Republic of Guinea

Introduction: Diabetes is a group of metabolic diseases characterized by chronic hyperglycemia resulting from a defect in insulin secretion or insulin action or both associated abnormalities. Objective: Our study aims to contribute in improving of health care of diabetic patients in the Municipality of Ratoma, Conakry, and Republic of Guinea. Methods: This study is a prospective and descriptive cross-sectional study lasting of 4 months, from February 16 to June 16, 2021. Results: The study involved 300 patients whose blood and urine were examined, 17% of the patients were positive, therefore diabetic. Glycosuria was positive on an empty stomach in 87%. Abnormal parameters were found as followed: Urobilinogen with 97%, Blood with 97%, Optical Density with 90%, Nitrite with 84%, pH with 83%, Ketone Bodies with 76%, Bilirubin with 73%, presence of Proteins in 75%, and Leukocytes in 71%. The evolution of diabetes in 20 patients with the HbA1c test, i.e. 32% and the majority of the 20 diabetic patients had HbA1c levels between 4 to 5.60% with 7 patients, i.e. 35% followed by those with rate between < 4% and 6.80% to 7.20% with 5 patients each, i.e. 25% (cumulative 50% of patients); 3 diabetic patients whose hemoglobin were severely affected by glucose had high HbA1c levels between 8.80 and 9.60%, i.e. 10%, and 1 patient with an HbA1c level of 11.40%, i.e. 5%. THBs were low in 20 patients, about 32%. This study found respectively: hyperleukocytosis (10%), hyperneutrophilia (10%), hypermonocytosis (16%), hyperlymphocytosis (13%) among the diabetic patients and alongside, 32 diabetic patients suffered from hypoleukocytosis (19%), hyponeutrophilia (8%), hypolymphocytosis (8%) and 35% from hypomonocytosis. Frustrated anemia were found in 75%, moderate anemia in 20% and severe anemia in 5%, while 25% of diabetic patients suffered from Microcytic anemia and 75% from Normocytic anemia and 15% of diabetic patients suffered also from Hypochromic anemia and 85% of diabetic patients suffered from Normochromic anemia. Female sex was the most represented with 59% against 41% for male sex. All age groups were affected by diabetes, however, age group of 61 to 80 years were the most affected with a prevalence of 38% followed by those of 41 to 60 years and 21 to 40 with respectively 35% and 22%. The least represented age group were less than or equal to 20 years old with 5%. Housewives with 35% were the most affected followed by Commercial Agents, Pupils/Students and Administrative Agents with 22%, 10% and 8% respectively. The Married were the most with a prevalence of 83% against 14% among Singles and only 3% among Widowed. The majority of patients were from the commune of Ratoma, i.e. a prevalence of 81% followed by those from Matoto with 9%. Patients from elsewhere accounted for only 5%. Conclusion: This study revealed that in diabetic patients

Immunosuppression, infection, and epidermal compromise - an aetiological triad for necrotising otitis externa which highlights potential modifiable risk factors.

A key clinical feature of necrotising otitis externa is granulation tissue arising from the ear canal, representing epidermal compromise. The aim of this work was to explore the role of epidermal compromise in the aetiology of necrotising otitis externa. A structured risk factor history was taken from 54 patients diagnosed with necrotising otitis externa between 2017 and 2022. Primary care records were also reviewed. A total of 94 per cent of patients reported incidents of potential epidermal compromise preceding severe pain onset, including a 35 per cent incidence of ear syringing. A total of 94 per cent of patients were immunosuppressed, including 78 per cent with diabetes. All patients had medical co-morbidities. This study proposed an aetiological triad for necrotising otitis externa: immunosuppression, infection and epidermal compromise. Epidermal compromise is a potentially modifiable risk factor for necrotising otitis externa. Meticulous primary ear care for older adult, diabetic and immunosuppressed patients is recommended. These populations should never undergo ear syringing and should avoid ear canal trauma and prolonged exposure to moisture.

Educação permanente centrada na abordagem ao paciente com diabetes mellitus: importância da equipe multiprofissional

Diabetes, like other chronic diseases, requires constant monitoring and self-care. The objective was to identify the contributions of the multidisciplinary team for the prevention of complications and treatment of diabetes mellitus in patients. This is a descriptive exploratory study, with a quantitative approach, carried out with 31 health professionals, working in Health Units in Curitiba/PR. It resulted in the identification of subjects for which professionals would like to be better trained and the items considered important for stimulating and qualifying care for diabetic patients. A Care Card was prepared, encouraging self-care, placing the team and the patient as allies in controlling the disease. It is considered that an active and trained multidisciplinary team, with an improved view of the disease and its determinants, combined with a patient who is knowledgeable about self-care, is a favorable combination for successful treatment, prevention of chronic complications, and reduction of damage to the individual's health

Practice Guidelines of Nursing and Midwifery Diabetes Care – 2023. A position statement of Polish federation for education in Diabetology

Abstract Introduction. The history of recommendations by the Polish Federation for Education in Diabetology dates back to 2006, when guidelines for nurses/midwifes working with diabetic patients were first drawn up. However, the development of nurses and midwifes? competences requires stronger actions that foster a transition from experience-based towards evidence-based practice. Aim. The aim of this publication is to present a set of procedures describing nursing interventions in diabetes care, including currently available scientific evidence and clinical experience of specialists involved in the care of diabetic patients. Material and methods. The study involved a literature review of selected areas of nursing practice in diabetes care. When compiling the material, the priority was to use data from (in order of significance): randomized controlled clinical trials and their meta-analyses, observational studies and other studies with lower levels of evidence. Results. Based on an analysis of the collected material, 15 procedures and 2 guidelines have been developed, describing selected aspects of nursing interventions in diabetic patients. Each of the procedures details key recommendations on diabetes care, arranged in accordance of the significance ascribed to the scientific evidence analyzed. Conclusions. The 2023 PFED guidelines on nursing diabetes care are the effect of the evaluation of the previous versions and comprise an updated, considerably more extensive, comprehensive and evidence-based set of practices. The major asset of these guidelines is their interdisciplinarity, reflected in the fact that the final version of the publication was approved by consultants in numerous nursing fields, a consultant in diabetology, and the President of the Polish Federation for Education in Diabetology, who all represent the medical community. The authors experience gained during work on international recommendations (New Insulin Delivery Recommendations) played an important role when formulating the present guidelines.

МАРКЕТИНГОВЫЙ АНАЛИЗ ФАРМАЦЕВТИЧЕСКОГО РЫНКА ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ ДЛЯ ЛЕЧЕНИЯ САХАРНОГО ДИАБЕТА 2-ГО ТИПА

Content analysis of statistical data for the Russian Federation and the Belgorod region showed a trend of increasing prevalence of type 2 diabetes mellitus. Currently, according to the State Register of Patients with Diabetes Mellitus and the Federal State Statistics Service, as of January 1, 2022, more than 4.5 million patients were registered in Russia, which is slightly more than 3.1% of the country's population. In the Belgorod region on 01.01.2021, the number of patients with type 2 diabetes was 57,634 people or 3.74% of the population of the region. The increase in the dynamics of the prevalence of diabetes mellitus, its complications, disability and mortality determine the expediency of studying the range of lipid-lowering drugs to improve medical and pharmaceutical care for diabetic patients. The purpose of the study was a marketing analysis of the pharmaceutical market of medicines for the treatment of type 2 diabetes mellitus. Information and reference literature on the range of medicines registered and approved for use in the Russian Federation, Internet resources, supplier offers, scientific works of Russian and foreign scientists were used as objects of research. The study and analysis of the assortment were carried out using a wide range of methods and approaches to research, including generalization and data mining, general scientific analysis tools, statistical methods. In the course of the study of the range of lipid-lowering drugs in the domestic and local markets, the multidimensional characteristics of these segments were obtained. Based on the maximum indicators of the assortment, macro- and mesocontures of target segments of the markets of medicines for the treatment of type II diabetes mellitus have been developed: domestic and Belgorod markets of drugs for the treatment of type II diabetes mellitus The types are represented by: mostly subgroup A10BA - "Biguanides", according to the active substance "Metformin". In terms of composition, drugs with one active ingredient in solid dosage form in the form of tablets are leading. The coefficient of assortment renewal in the Russian pharmaceutical market was 0.75, in Belgorod – 0.51. In general, the study showed that the pharmaceutical market of the Russian Federation has a significant resource for pharmacotherapy of type 2 diabetes mellitus, which provides an opportunity for interaction between pharmaceutical specialists and healthcare professionals to provide pharmaceutical and medical care.

The World-Wide Adaptations of Diabetic Management in the Face of COVID-19 and Socioeconomic Disparities: A Scoping Review.

Diabetes is an increasingly prevalent chronic disease throughout the world. It is imperative for patients to have access to reliable treatment and resources in order to avoid long-term complications. Economic and social factors contribute to the accessibility of these resources and have a direct impact on diabetes management. Socioeconomic status (SES) presents challenges to diabetic management due to financial and geographical access to care, medications, educational resources, healthy food options, and physical activity. The coronavirus (COVID-19) pandemic exacerbated these challenges, especially during the height of lockdowns. Therefore, it is important to gain insight into how the pandemic challenged diabetes management, taking into consideration socioeconomic disparities. The objective is to assess how the COVID-19 pandemic has impacted the care of chronic diabetic patients internationally and determine how these outcomes vary between patients of different socioeconomic classes. The following study was designed as a scoping review and utilized PubMed, EMBASE, CINAHL, and Web of Science. A Boolean search strategy combined search terms as follows: (((COVID-19) AND (diabetes)) AND ((socioeconomic factors) OR (social inequality OR standard of living))) AND (treatment OR management). Inclusion criteria included studies addressing diabetic patients, socioeconomic variables (income, occupation, level of education, and ethnicity), glycemic control, and degree of access to quality healthcare. Studies exploring the pathophysiology of COVID-19 or diabetes mellitus were excluded. In addition, studies were chosen between the years 2020 and 2022. The search resulted in 214 articles. The full-text assessment was then conducted on the remaining 67 articles. After screening for eligibility and relevance, 19 articles were retained for this review. The results of this study indicate that 8 out of the 18 studies revealed worse outcomes for those with diabetes mellitus and concomitant COVID-19 infection. Patients with diabetes were more likely to be hospitalized and represent a larger percentage of COVID-19 fatalities. In addition, patients with diabetes and co-morbid COVID-19 infection were more likely to have a higher hemoglobin A1c (HbA1c), belong to a lower SES, and have worse glycemic control due to pandemic-associated lockdown. In order to combat the effects of the pandemic, many countries created novel and innovative management strategies. Overall, there are positive and negative effects from the pandemic on diabetic management strategies. This scoping review identified successes in diabetic treatment under pandemic conditions and areas that need optimization. The successful adaptations of many nations convey the capacity for new policy implementation to care for diabetic patients regardless of SES.

Extent of awareness of diabetic foot care in diabetic patients and their families at AL Baha city, Saudi Arabia

Extent of awareness of diabetic foot care in diabetic patients and their families at AL Baha city, Saudi Arabia

Association of diabetes mellitus with depression, anxiety and quality of life

"Introduction: Many studies demonstrated that psychological factors play an important role in the development and course of diabetes mellitus. Objective: The focus of our research, among the first in a Hungarian sample, was to examine depression and anxiety levels and diabetes-specific quality of life in people with type 2 diabetes, to explore gender differences, and to analyze the relationship of depression and anxiety with diabetes-specific quality of life. Method: 157 people diagnosed with type 2 diabetes (women: 58.6%, men: 40.1%) were assessed for levels of depression Center for Epidemiologic Studies Depression Scale – Hungarian version), anxiety (Spielberger’s Trait Anxiety Questionnaire) and diabetes-specific quality of life (Audit of Diabetes-Dependent Quality of Life – Hungarian version). Results: 65% of subjects did not show depressive symptoms, but 56.1% showed moderate trait anxiety. More severe depressive symptoms (U = 1625, p<0.001) and higher trait anxiety (U = 1556, p<0.001) were significantly more frequent in women compared to men. Depressive symptom severity and trait anxiety were inversely and weakly correlated with diabetes-specific quality of life. Discussion: In summary, the results suggest that the psychological state (depressive symptoms and anxiety) in patients with type 2 diabetes is associated with their diabetes-specific quality of life. Women with diabetes also have higher levels of depression and anxiety compared to men with diabetes. Conclusion: Psychological assessment of patients’ depressive and anxiety symptoms and quality of life is recommended in the care of diabetic patients, and appropriate treatment is recommended as needed. This may improve patients’ quality of life, therapeutic cooperation and disease prognosis."

PSUN225 Assessment of Nutrition Knowledge and its Relationship with Metabolic Control in Patients with Diabetes

Abstract Introduction Medical nutrition therapy (MNT) is central in the overall diabetes management plan, with absolute decreases in HbA1c of up to 2.0% (in type 2 diabetes) and up to 1.9% (in type 1 diabetes) at 3–6 months. Continuing MNT support is helpful in maintaining glycemic improvements. We evaluated nutritional knowledge level about diabetes and its relation to metabolic control in 50 adult diabetic patients hospitalized in the medical-surgical area in our Hospital. Materials and methods We conducted a descriptive, observational and cross-sectional study from October to November 2020. We performed a validated structured survey that consists of 13 true or false questions about nutritional diabetes knowledge. In addition, patients were asked about the role of the nutritionist in the care of diabetic patients. Also, medical charts were reviewed. Results The mean age was 66 years (range 33-88), mostly males (62%). Sixty-percent of patients were older adults. Only one female patient had type-1 diabetes, the rest had type 2. Mean diabetes duration was 11±10 years. Fifty-six percent of patients had poor metabolic control. The mean glycosylated hemoglobin was 8,6%. The mean body mass index was 32,1Kg/m2. Ninety-two point nine percent of adults and 68,0% of elderly patients were overweight or obese. Sixty-four percent of patients had an appointment with nutritionist. Half of them considered having fulfilled the nutritional treatment. In regard to the survey the average number of correct answers was 8 questions (61,5%). Sufficient diabetic nutritional knowledge (≥70% of the correct answers) was recorded in 30,0% of patients, regular (between 51% and 69% of the correct answers) in 56,0% and insufficient (≤50% of the correct answers) in 14,0%. There was scant knowledge about vegetables and fruits in relation with diabetes. Those with high level of education did not display more knowledge. There was no association between level of knowledge and metabolic control. Eighty percent of those who showed sufficient knowledge had poor metabolic control, compared to 33.3% of those with insufficient knowledge. Of 32 patients that had a nutritionist appointment only 2 had insufficient knowledge and more than 90% had more than 50% of correct answers. In contrast, 71,4% of those without a nutritionist appointment showed insufficient knowledge. Conclusions The diabetic inpatients that had an appointment with nutritionist had regular and sufficient knowledge, compared to most of those without this appointment that showed insufficient knowledge. However, the overall awareness about fruits and vegetables was poor. Although most of the surveyed patients did not show insufficient knowledge, they were overweight or obese and had poor metabolic control. We believe the nutritionist is an essential part of the interdisciplinary team. More studies are warranted to evaluate nutrition knowledge in diabetic patients to plan educational strategies in this population. Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m.